Nicola M. Parry, BVSc, MRCVS, MSc, DACVP, FRSPH, ELS

The FDA has finalized its guidance on how to synchronize development of antimicrobials and antimicrobial susceptibility test devices.

A new portable metagenomic technology allowed investigators to perform real-time analysis of viral genomes during a 2018 Lassa fever outbreak in Nigeria.

Despite promising early results, dolutegravir monotherapy should no longer be used as HIV maintenance therapy, a new study concludes.

Investigators have identified Marburg virus in Sierra Leone bats, marking the first time the hemorrhagic fever has been discovered in West Africa.

Antibiotic cycling is not linked to a reduced incidence of health care-associated MRSA or Clostridium difficile infection, a new study shows.

Studies that do not consider time of infection may overestimate the impact of hospital-acquired infections on patient outcomes, according to the results of a new study.

Patients with uncomplicated gram-negative bacteremia respond just as well to a 7-day course of antibiotics as they do a 14-day regimen, according to a new study.

The disease is now widespread among rodents in New Orleans, posing an increased public health risk of rat lungworm disease to people in the area.

A new study suggests that combined antiretroviral treatment in patients with HIV does not prevent viral load rebound in semen after the treatment is paused.

Scientists have identified a new strategy to generate novel antibiotics.

HIV-specific ex-vivo expanded T cell therapy appears to be safe and well tolerated in people with HIV taking antiretroviral therapy who are virally suppressed.

A large outbreak of infections caused by the yeast Candida auris remains ongoing in health care facilities in New York City and poses a concerning public health threat.

Two public health experts discuss the recent rapid increase in incidence of infectious diseases that has been linked with injection drug use.

The incidence of Neisseria meningitidis serogroup W is rising in Georgia.

A recent molecular study has confirmed the causative agent involved in a large epidemic of Rocky Mountain spotted fever in humans and dogs in Mexicali, in Baja California, Mexico.

A recent report shows that patients receiving eculizumab remain extremely susceptible to meningococcal disease, including from nongroupable Neisseria meningitidis strains, despite being vaccinated against the disease.